Motif ID | Motif Logo | Scanned Score Distribution | Frequency of Motif | Replicability Score | Evolutionary Conservation Score | Gene Targets | Gene Ontology of CpGMM targets |
---|---|---|---|---|---|---|---|
CG_hsf1_promoter_n_RM_12_63_4 | ![]() |
![]() |
4 | 0.75 | 4.24E-04 | HOXB6 | erythrocyte homeostasis [BP] |
CG_hsf1_promoter_n_RM_14_16_4 | ![]() |
![]() |
5 | 0.75 | 6.25E-04 | PDGFRB, ISG20L2, VPS4B, SYNCRIP, UBQLN4, LDB2, SFMBT1, FOXL2, ZBTB46, SSBP2, SIN3A, FEV | nucleus [CC] |
CG_hsf1_promoter_n_RM_14_26_2 | ![]() |
![]() |
3 | 0.5 | 4.19E-04 | HSPG2, HS6ST1, HS3ST1, CYTH1 | regulation of ARF protein signal transduction [BP], glycosaminoglycan metabolic process [BP], sulfotransferase activity [MF], glycosaminoglycan biosynthetic process [BP] |
CG_hsf1_promoter_n_RM_14_73_9 | ![]() |
![]() |
7 | 0.75 | 3.53E-04 | BSCL2 | negative regulation of lipid catabolic process [BP] |
CG_hsf1_promoter_n_RM_12_31_2 | ![]() |
![]() |
5 | 0.75 | 9.02E-05 | HOXA5, GPR143, CEBPA | cell-cell signaling involved in mammary gland development [BP], response to vitamin B2 [BP], L-DOPA binding [MF], L-DOPA receptor activity [MF] |
CG_hsf1_promoter_n_RM_12_42_5 | ![]() |
![]() |
4 | 0.75 | 4.24E-04 | DGKQ, KCNJ11 | response to ATP [BP] |
CG_hsf1_promoter_n_RM_14_68_5 | ![]() |
![]() |
4 | 0.5 | 2.72E-04 | SLC6A4 | negative regulation of cerebellar granule cell precursor proliferation [BP] |
CG_hsf1_promoter_n_RM_12_94_4 | ![]() |
![]() |
5 | 0.75 | 4.08E-04 | IRS2, TWIST1 | cell proliferation involved in heart valve development [BP], positive regulation of fatty acid beta-oxidation [BP], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP] |
CG_hsf1_promoter_n_RM_14_77_2 | ![]() |
![]() |
4 | 0.5 | 2.75E-04 | MECP2, NOTCH1, SULT4A1, CHST1 | double-stranded methylated DNA binding [MF], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], regulation of extracellular matrix assembly [BP], keratan sulfotransferase activity [MF], venous endothelial cell differentiation [BP], sulfotransferase activity [MF] |
CG_hsf1_promoter_n_RM_14_18_2 | ![]() |
![]() |
3 | 0.5 | 1.37E-04 | NAMPT | nicotinamide metabolic process [BP], nicotinamide phosphoribosyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_14_20_5 | ![]() |
![]() |
3 | 0.5 | 2.85E-04 | CERS2, CERS5 | ceramide biosynthetic process [BP], sphingosine N-acyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_16_8_1 | ![]() |
![]() |
4 | 0.5 | 1.24E-04 | HMGB2, SLX4, POLR2E | Slx1-Slx4 complex [CC], ERCC4-ERCC1 complex [CC], crossover junction endodeoxyribonuclease activity [MF], base-excision repair, DNA ligation [BP], Holliday junction resolvase complex [CC], DNA repair [BP], nucleotide-excision repair [BP], 3'-flap endonuclease activity [MF], DNA double-strand break processing involved in repair via single-strand annealing [BP] |
CG_hsf1_promoter_n_RM_12_96_6 | ![]() |
![]() |
3 | 0.5 | 1.11E-04 | NCOA6, MED16, MTHFR | thyroid hormone receptor binding [MF], ligand-dependent nuclear receptor transcription coactivator activity [MF], methylenetetrahydrofolate reductase (NADPH) activity [MF] |
CG_hsf1_promoter_n_RM_12_104_4 | ![]() |
![]() |
5 | 0.75 | 2.07E-04 | UFSP1, NR3C1 | UFM1 hydrolase activity [MF], glucocorticoid receptor activity [MF] |
CG_hsf1_promoter_n_RM_12_54_4 | ![]() |
![]() |
3 | 0.5 | 4.16E-04 | FASN | acetyl-CoA metabolic process [BP] |
CG_hsf1_promoter_n_RM_12_44_4 | ![]() |
![]() |
2 | 0.5 | 2.94E-04 | BUD13, ALDH18A1 | RES complex [CC], glutamate 5-kinase activity [MF], glutamate-5-semialdehyde dehydrogenase activity [MF], ornithine biosynthetic process [BP] |
CG_hsf1_promoter_n_RM_14_28_2 | ![]() |
![]() |
6 | 0.5 | 3.13E-04 | HMGB1, HDLBP, LCAT, NFYB | repressing transcription factor binding [MF], negative regulation of apoptotic cell clearance [BP], high-density lipoprotein particle [CC] |
CG_hsf1_promoter_n_RM_12_114_3 | ![]() |
![]() |
2 | 0.5 | 1.82E-04 | SOCS1, QDPR, DRD2, EZR, DOCK6, TNKS1BP1, WNK3, ANAPC1, MGEA5, RHOG, EIF5A2, ARHGAP29 | positive regulation of protein complex disassembly [BP], positive regulation of growth hormone secretion [BP], positive regulation of establishment of protein localization to plasma membrane [BP], cytosol [CC], regulation of ion homeostasis [BP] |
CG_hsf1_promoter_n_RM_14_35_2 | ![]() |
![]() |
3 | 0.75 | 4.15E-04 | NIN | centrosome-templated microtubule nucleation [BP] |
CG_hsf1_promoter_n_RM_12_58_6 | ![]() |
![]() |
3 | 0.5 | 4.17E-04 | GRM6 | new growing cell tip [CC] |
CG_hsf1_promoter_n_RM_14_23_6 | ![]() |
![]() |
3 | 0.5 | 3.07E-04 | DLL1, NOTCH1, SYT7, DVL2 | left/right axis specification [BP], neuronal stem cell maintenance [BP], Notch receptor processing [BP], segment specification [BP], compartment pattern specification [BP], regulation of calcium ion-dependent exocytosis [BP] |
CG_hsf1_promoter_n_RM_12_27_4 | ![]() |
![]() |
3 | 0.5 | 3.29E-04 | IMPAD1, RPS6KA5, WAPAL, EXTL2 | histone H2A-S1 phosphorylation [BP], alpha-1,4-N-acetylgalactosaminyltransferase activity [MF], 3'-nucleotidase activity [MF], intracellular membrane-bounded organelle [CC] |
CG_hsf1_promoter_n_RM_12_67_4 | ![]() |
![]() |
4 | 0.75 | 4.43E-04 | CLIP1, TBX18 | negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], macropinosome [CC] |
CG_hsf1_promoter_n_RM_12_56_3 | ![]() |
![]() |
4 | 0.75 | 3.21E-04 | SORT1, CDC42EP3 | neurotensin receptor activity, non-G-protein coupled [MF], cytoskeletal regulatory protein binding [MF] |
CG_hsf1_promoter_n_RM_16_22_2 | ![]() |
![]() |
3 | 0.5 | 2.45E-04 | FGFR2, ADRA1D, SLX4, KCNJ4, KCNH2 | ERCC4-ERCC1 complex [CC], negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [BP], fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP], Holliday junction resolvase complex [CC], fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP], inward rectifier potassium channel activity [MF], fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP], voltage-gated potassium channel complex [CC], coronal suture morphogenesis [BP] |
CG_hsf1_promoter_n_RM_14_43_4 | ![]() |
![]() |
2 | 0.5 | 6.42E-04 | TSHZ3, ARRDC3, NKX2-2 | ventral spinal cord interneuron fate determination [BP], negative regulation of heat generation [BP], type B pancreatic cell fate commitment [BP], negative regulation of locomotion involved in locomotory behavior [BP], ureteric peristalsis [BP] |
CG_hsf1_promoter_n_RM_12_93_4 | ![]() |
![]() |
3 | 0.75 | 3.04E-04 | PRKAA1, IL6ST, CPT1B | regulation of fatty acid oxidation [BP], regulation of Notch signaling pathway [BP] |
CG_hsf1_promoter_n_RM_12_29_6 | ![]() |
![]() |
2 | 0.5 | 3.83E-04 | BET1L | retrograde transport, endosome to Golgi [BP] |
CG_hsf1_promoter_n_RM_14_30_4 | ![]() |
![]() |
6 | 0.5 | 3.02E-04 | MAP6D1, KRT13, CLIP1, TLN1, RPS6KA2 | extracellular vesicular exosome [CC], axon guidance [BP], macropinosome [CC], N-terminal peptidyl-L-cysteine N-palmitoylation [BP] |
CG_hsf1_promoter_n_RM_14_5_4 | ![]() |
![]() |
3 | 0.5 | 3.28E-04 | EPHA2, DIAPH1, RASGRP2 | leading edge membrane [CC], ruffle membrane [CC] |
CG_hsf1_promoter_n_RM_12_82_2 | ![]() |
![]() |
3 | 0.75 | 1.94E-04 | TBX18, TFAP2A | optic vesicle morphogenesis [BP], negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], RNA polymerase II transcription corepressor activity [MF], optic cup structural organization [BP] |
CG_hsf1_promoter_n_RM_14_79_2 | ![]() |
![]() |
3 | 0.75 | 3.83E-04 | BCAT2, CAMK2B, PPP3CA | L-leucine transaminase activity [MF], isoleucine catabolic process [BP], inhibitory G-protein coupled receptor phosphorylation [BP], branched-chain-amino-acid transaminase activity [MF], regulation of skeletal muscle adaptation [BP], L-isoleucine transaminase activity [MF], activation of meiosis involved in egg activation [BP], branched-chain amino acid biosynthetic process [BP], transition between fast and slow fiber [BP], L-valine transaminase activity [MF] |
CG_hsf1_promoter_n_RM_12_138_6 | ![]() |
![]() |
6 | 0.75 | 3.41E-04 | NKX2-2 | ventral spinal cord interneuron fate determination [BP], type B pancreatic cell fate commitment [BP] |
CG_hsf1_promoter_n_RM_12_20_3 | ![]() |
![]() |
2 | 0.5 | 3.47E-04 | YBX2 | translation regulator activity [MF] |
CG_hsf1_promoter_n_RM_12_71_6 | ![]() |
![]() |
2 | 0.5 | 4.06E-04 | DLG4, NCBP2, ALYREF, JUP, ENTPD4, LONP1 | mitochondrial heavy strand promoter anti-sense binding [MF], gamma-catenin-TCF7L2 complex [CC], oxidation-dependent protein catabolic process [BP], mitochondrial light strand promoter anti-sense binding [MF], structural constituent of cell wall [MF], termination of RNA polymerase II transcription [BP], P2Y1 nucleotide receptor binding [MF], UDP catabolic process [BP] |
CG_hsf1_promoter_n_RM_12_8_5 | ![]() |
![]() |
2 | 0.5 | 2.99E-04 | LCAT, HDLBP | high-density lipoprotein particle [CC] |
CG_hsf1_promoter_n_RM_12_117_3 | ![]() |
![]() |
3 | 0.75 | 2.70E-04 | DVL2, PAX6, NEUROD2 | hindbrain development [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP] |
CG_hsf1_promoter_n_RM_14_22_2 | ![]() |
![]() |
3 | 0.5 | 8.10E-04 | NTAN1, DSCAM | locomotory behavior [BP], protein-N-terminal asparagine amidohydrolase activity [MF], dendrite self-avoidance [BP], post-embryonic retina morphogenesis in camera-type eye [BP], positive regulation of axon extension involved in axon guidance [BP] |
CG_hsf1_promoter_n_RM_12_35_3 | ![]() |
![]() |
2 | 0.5 | 9.04E-05 | GCLM | glutamate-cysteine ligase catalytic subunit binding [MF], positive regulation of glutamate-cysteine ligase activity [BP] |
CG_hsf1_promoter_n_RM_12_75_4 | ![]() |
![]() |
3 | 0.5 | 3.45E-04 | MAPK9, AKT1 | positive regulation of nitric oxide biosynthetic process [BP] |
CG_hsf1_promoter_n_RM_12_52_8 | ![]() |
![]() |
3 | 0.75 | 3.56E-04 | ITPK1, SLC8A1 | inositol tetrakisphosphate 1-kinase activity [MF], sodium ion export [BP], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF] |
CG_hsf1_promoter_n_RM_12_2_4 | ![]() |
![]() |
4 | 0.75 | 4.49E-04 | SSBP3, BMP4, COLEC12, KCNMA1, KCNG3 | BMP signaling pathway involved in renal system segmentation [BP], bud dilation involved in lung branching [BP], prechordal plate formation [BP], negative regulation of metanephric S-shaped body morphogenesis [BP], negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP], BMP signaling pathway involved in ureter morphogenesis [BP], negative regulation of cell volume [BP], negative regulation of glomerulus development [BP], negative regulation of metanephric comma-shaped body morphogenesis [BP], ureter epithelial cell differentiation [BP], positive regulation of cardiac muscle fiber development [BP], inner ear receptor cell differentiation [BP], specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP], negative regulation of mesenchymal cell proliferation involved in ureter development [BP], pulmonary artery endothelial tube morphogenesis [BP], intermediate mesodermal cell differentiation [BP], cellular potassium ion homeostasis [BP], midbrain-hindbrain boundary initiation [BP], eye blink reflex [BP], negative regulation of cell proliferation involved in heart morphogenesis [BP], BMP signaling pathway involved in nephric duct formation [BP], protein homooligomerization [BP] |
CG_hsf1_promoter_n_RM_12_46_2 | ![]() |
![]() |
3 | 0.75 | 2.67E-04 | DSCAM, CELSR1, AIFM2 | apoptotic mitochondrial changes [BP], protein localization involved in establishment of planar polarity [BP], positive regulation of axon extension involved in axon guidance [BP] |
CG_hsf1_promoter_n_RM_12_106_4 | ![]() |
![]() |
3 | 0.75 | 3.38E-04 | LHX3, PTK2, FLNA, PDGFA, SMURF1 | regulation of smooth muscle cell migration [BP], protein localization to cell surface [BP], placenta development [BP] |
CG_hsf1_promoter_n_RM_14_38_6 | ![]() |
![]() |
4 | 0.5 | 3.23E-04 | PITPNM3 | phosphatidylinositol metabolic process [BP] |
CG_hsf1_promoter_n_RM_14_24_2 | ![]() |
![]() |
5 | 0.5 | 4.17E-04 | PITPNA, SLC26A6, LRP8 | ammon gyrus development [BP], formate transmembrane transporter activity [MF], stearic acid binding [MF] |
CG_hsf1_promoter_n_RM_12_127_9 | ![]() |
![]() |
3 | 0.75 | 2.89E-04 | NOTCH1 | somatic stem cell division [BP] |
CG_hsf1_promoter_n_RM_12_50_3 | ![]() |
![]() |
3 | 0.5 | 2.84E-04 | TXN, EGR2 | rhombomere 3 formation [BP], rhombomere 5 formation [BP], response to thyroxine stimulus [BP], protein export from nucleus [BP], regulation of neuronal synaptic plasticity [BP] |
CG_hsf1_promoter_n_RM_14_7_5 | ![]() |
![]() |
3 | 0.5 | 3.90E-04 | NFIB | negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP] |
CG_hsf1_promoter_n_RM_12_45_7 | ![]() |
![]() |
4 | 1.0 | 3.56E-04 | NOTCH1, SLIT1, ARRDC3, BCL11A | negative regulation of heat generation [BP], negative regulation of locomotion involved in locomotory behavior [BP], negative regulation of neurogenesis [BP], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], regulation of extracellular matrix assembly [BP], negative regulation of axon extension [BP], venous endothelial cell differentiation [BP], hemopoiesis [BP], establishment of nucleus localization [BP] |
CG_hsf1_promoter_n_RM_12_103_3 | ![]() |
![]() |
4 | 0.5 | 1.97E-04 | SEPT12, M1AP | male meiosis chromosome separation [BP], sperm annulus [CC] |
CG_hsf1_promoter_n_RM_12_110_6 | ![]() |
![]() |
6 | 0.75 | 4.58E-04 | NGF, CYP2J2 | arachidonic acid 14,15-epoxygenase activity [MF], nerve growth factor receptor binding [MF], arachidonic acid 11,12-epoxygenase activity [MF], linoleic acid epoxygenase activity [MF], positive regulation of nerve growth factor receptor signaling pathway [BP] |
CG_hsf1_promoter_n_RM_16_21_1 | ![]() |
![]() |
2 | 0.5 | 6.05E-04 | GRIK3 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [BP] |
CG_hsf1_promoter_n_RM_16_4_2 | ![]() |
![]() |
3 | 0.5 | 2.91E-04 | DIAPH1, KCNJ11 | ion channel binding [MF] |
CG_hsf1_promoter_n_RM_16_14_2 | ![]() |
![]() |
7 | 0.5 | 2.70E-04 | ADA | negative regulation of adenosine receptor signaling pathway [BP], negative regulation of penile erection [BP], dATP catabolic process [BP], germinal center B cell differentiation [BP], xanthine biosynthetic process [BP], deoxyadenosine catabolic process [BP] |
CG_hsf1_promoter_n_RM_14_15_1 | ![]() |
![]() |
2 | 0.5 | 8.67E-05 | LHX3 | medial motor column neuron differentiation [BP] |
CG_hsf1_promoter_n_RM_14_9_4 | ![]() |
![]() |
3 | 0.5 | 3.39E-04 | RBBP7, AXIN2, BAD | cellular heat acclimation [BP], mRNA stabilization [BP], regulation of chondrocyte development [BP], cellular response to chromate [BP] |
CG_hsf1_promoter_n_RM_12_105_4 | ![]() |
![]() |
3 | 0.75 | 2.11E-04 | SAP130, TCF3, SUPT3H, TADA1 | histone H3 acetylation [BP], STAGA complex [CC], histone acetyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_12_47_2 | ![]() |
![]() |
3 | 0.5 | 2.68E-04 | IL11 | interleukin-11 receptor binding [MF] |
CG_hsf1_promoter_n_RM_12_19_2 | ![]() |
![]() |
2 | 0.5 | 3.57E-04 | SORT1, PITPNA, APIP, SOX10 | neurotensin receptor activity, non-G-protein coupled [MF], extrinsic to mitochondrial outer membrane [CC], stearic acid binding [MF], methylthioribulose 1-phosphate dehydratase activity [MF] |
CG_hsf1_promoter_n_RM_12_18_4 | ![]() |
![]() |
3 | 0.5 | 2.83E-04 | SDC1 | myoblast development [BP] |
CG_hsf1_promoter_n_RM_12_32_5 | ![]() |
![]() |
3 | 0.75 | 3.02E-04 | CYB561 | transmembrane electron transfer carrier [MF] |
CG_hsf1_promoter_n_RM_14_76_2 | ![]() |
![]() |
4 | 0.5 | 5.13E-04 | CBX4, ALYREF, PIAS2 | protein sumoylation [BP], nuclear speck [CC] |
CG_hsf1_promoter_n_RM_14_17_2 | ![]() |
![]() |
2 | 0.5 | 3.31E-04 | CYB561, NAMPT, LUZP1, TLR5, PPP3CA, SHANK1, IRF1 | neural fold bending [BP], determination of affect [BP], cellular response to mechanical stimulus [BP], regulation of excitatory postsynaptic membrane potential [BP], habituation [BP], nicotinamide phosphoribosyltransferase activity [MF], transmembrane electron transfer carrier [MF], somatostatin receptor binding [MF], transition between fast and slow fiber [BP] |
CG_hsf1_promoter_n_RM_16_3_3 | ![]() |
![]() |
7 | 0.5 | 3.91E-04 | DTNBP1, CDC42BPB | actin cytoskeleton reorganization [BP] |
CG_hsf1_promoter_n_RM_12_26_4 | ![]() |
![]() |
3 | 0.75 | 3.74E-04 | RAPH1, EZR, TWF1 | filopodium [CC] |
CG_hsf1_promoter_n_RM_14_32_5 | ![]() |
![]() |
3 | 0.5 | 2.70E-04 | SLC25A29, CBX4, PHIP, IGF2 | insulin receptor binding [MF], positive regulation of mitosis [BP], single-stranded RNA binding [MF], acyl carnitine transmembrane transporter activity [MF] |
CG_hsf1_promoter_n_RM_12_113_8 | ![]() |
![]() |
3 | 0.5 | 2.37E-04 | KDM5B, NUDT3, CYBA | negative regulation of glomerular filtration by angiotensin [BP], diphosphoinositol polyphosphate catabolic process [BP], diadenosine polyphosphate catabolic process [BP], histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], smooth muscle hypertrophy [BP], histone demethylase activity (H3-trimethyl-K4 specific) [MF] |
CG_hsf1_promoter_n_RM_12_115_3 | ![]() |
![]() |
3 | 0.75 | 4.68E-04 | SNTA1, CAMK2N1, SLC5A6, WNT7B, CADPS2 | biotin transport [BP], outer medullary collecting duct development [BP], synapse organization [BP], establishment or maintenance of polarity of embryonic epithelium [BP], pantothenate transmembrane transport [BP], postsynaptic membrane [CC], regulation of vasoconstriction by circulating norepinephrine [BP] |
CG_hsf1_promoter_n_RM_14_34_2 | ![]() |
![]() |
2 | 0.5 | 4.32E-04 | KDM5B | histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], histone demethylase activity (H3-trimethyl-K4 specific) [MF] |
CG_hsf1_promoter_n_RM_12_73_5 | ![]() |
![]() |
4 | 0.75 | 3.54E-04 | ENAH, SEPT12, SLC4A7 | cochlear nucleus development [BP], stress fiber [CC], sperm annulus [CC] |
CG_hsf1_promoter_n_RM_12_41_5 | ![]() |
![]() |
2 | 0.5 | 7.01E-04 | STAT5B | response to interleukin-2 [BP], development of secondary male sexual characteristics [BP] |
CG_hsf1_promoter_n_RM_12_39_3 | ![]() |
![]() |
2 | 0.5 | 3.35E-04 | SORT1, KIAA1161, CBX8, QSOX2 | nuclear membrane [CC], PcG protein complex [CC] |
CG_hsf1_promoter_n_RM_14_29_3 | ![]() |
![]() |
6 | 0.5 | 4.10E-04 | ITPK1 | inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF] |
CG_hsf1_promoter_n_RM_12_119_5 | ![]() |
![]() |
3 | 0.75 | 4.55E-04 | ACVR1 | endocardial cushion cell fate commitment [BP] |
CG_hsf1_promoter_n_RM_12_24_5 | ![]() |
![]() |
5 | 0.75 | 3.45E-04 | AMPH, SCRIB | synaptic vesicle endocytosis [BP] |
CG_hsf1_promoter_n_RM_12_30_5 | ![]() |
![]() |
2 | 0.5 | 3.66E-04 | HSPG2, BCL11B, STAT5B, ADA, UCN, WNT4, PDGFA | lipid metabolic process [BP], positive regulation of collagen biosynthetic process [BP], Peyer's patch development [BP], liver development [BP], regulation of lipid metabolic process [BP], response to estradiol stimulus [BP], T cell differentiation in thymus [BP] |
CG_hsf1_promoter_n_RM_12_15_4 | ![]() |
![]() |
4 | 0.75 | 3.34E-04 | SCTR, NACC2 | secretin receptor activity [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP] |
CG_hsf1_promoter_n_RM_16_23_1 | ![]() |
![]() |
3 | 0.5 | 3.03E-04 | CAMK2B, RAB3A | axonogenesis [BP], inhibitory G-protein coupled receptor phosphorylation [BP], maintenance of presynaptic active zone structure [BP], regulation of synaptic vesicle fusion to presynaptic membrane [BP], regulation of calcium ion transport [BP], activation of meiosis involved in egg activation [BP], clathrin-sculpted acetylcholine transport vesicle membrane [CC], sensory perception of touch [BP] |
CG_hsf1_promoter_n_RM_14_3_3 | ![]() |
![]() |
3 | 0.5 | 2.91E-04 | ITGB7, TEC, CRMP1, PLXND1, PITPNA, ITGB1 | integrin complex [CC], axon guidance [BP], integrin-mediated signaling pathway [BP], alpha3-beta1 integrin complex [CC], alpha9-beta1 integrin complex [CC] |
CG_hsf1_promoter_n_RM_12_91_3 | ![]() |
![]() |
3 | 0.75 | 3.87E-04 | GLRX2 | arsenate reductase (glutaredoxin) activity [MF] |
CG_hsf1_promoter_n_RM_14_39_3 | ![]() |
![]() |
4 | 0.5 | 2.08E-04 | AES, HDAC2, AXIN1, NFYB | repressing transcription factor binding [MF], negative regulation of Wnt receptor signaling pathway [BP], negative regulation of canonical Wnt receptor signaling pathway [BP] |
CG_hsf1_promoter_n_RM_12_133_3 | ![]() |
![]() |
4 | 0.5 | 2.97E-04 | MKX, RBBP7, PTCH1, ZBTB14, RUNX3 | negative regulation of transcription from RNA polymerase II promoter [BP] |
CG_hsf1_promoter_n_RM_12_97_2 | ![]() |
![]() |
2 | 0.5 | 4.57E-04 | DLL1 | negative regulation of auditory receptor cell differentiation [BP] |
CG_hsf1_promoter_n_RM_14_62_11 | ![]() |
![]() |
4 | 0.5 | 2.88E-04 | RAB5C, RAB3B, RAP1GAP | GTP catabolic process [BP] |
CG_hsf1_promoter_n_RM_14_81_5 | ![]() |
![]() |
4 | 0.5 | 3.15E-04 | SH3GL1 | GTPase binding [MF] |
CG_hsf1_promoter_n_RM_12_28_6 | ![]() |
![]() |
6 | 0.75 | 4.18E-04 | ST3GAL1, SOCS3, BCAR1, PKMYT1, NKX2-2, CRK, WNT7B, FGFR2, PRKD3, IGF2 | branching involved in labyrinthine layer morphogenesis [BP], lens fiber cell development [BP], protein phosphorylation [BP], embryonic placenta morphogenesis [BP], insulin receptor signaling pathway [BP], regulation of mitosis [BP], lung-associated mesenchyme development [BP], smoothened signaling pathway [BP] |
CG_hsf1_promoter_n_RM_14_11_5 | ![]() |
![]() |
5 | 0.5 | 3.43E-04 | KCNH2, KCNJ11 | potassium ion transmembrane transport [BP], inward rectifier potassium channel activity [MF] |
CG_hsf1_promoter_n_RM_14_75_6 | ![]() |
![]() |
7 | 0.75 | 4.64E-04 | NUP62, SLC1A2, HOMER1 | glutamate:sodium symporter activity [MF], protein complex scaffold [MF], regulation of glucose transport [BP], nucleocytoplasmic shuttling complex [CC], type 5 metabotropic glutamate receptor binding [MF] |
CG_hsf1_promoter_n_RM_12_49_3 | ![]() |
![]() |
3 | 0.75 | 1.95E-04 | ADCY9, AHI1, NFIB | negative regulation of mesenchymal cell proliferation involved in lung development [BP], pronephric duct morphogenesis [BP], Kupffer's vesicle development [BP], pronephric nephron tubule morphogenesis [BP], cerebellar mossy fiber [CC], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP], adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP] |
CG_hsf1_promoter_n_RM_14_74_6 | ![]() |
![]() |
7 | 0.75 | 5.10E-04 | SSBP3, GAREM, AKT1 | cellular response to epidermal growth factor stimulus [BP], prechordal plate formation [BP], midbrain-hindbrain boundary initiation [BP], glycogen cell differentiation involved in embryonic placenta development [BP] |
CG_hsf1_promoter_n_RM_12_40_5 | ![]() |
![]() |
3 | 0.5 | 4.74E-04 | EPHA2 | notochord cell development [BP] |
CG_hsf1_promoter_n_RM_12_83_5 | ![]() |
![]() |
3 | 0.75 | 3.17E-04 | NR3C1, ANKLE2, NCOA2 | glucocorticoid receptor activity [MF], mitotic nuclear envelope reassembly [BP], histone acetyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_12_34_2 | ![]() |
![]() |
4 | 0.75 | 4.07E-04 | KPNA4, ARFGAP3, NACC2 | protein transporter activity [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP] |
CG_hsf1_promoter_n_RM_12_137_5 | ![]() |
![]() |
4 | 0.75 | 3.06E-04 | ST6GALNAC4 | (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_14_6_3 | ![]() |
![]() |
3 | 0.5 | 2.93E-04 | SIN3A, LMO2 | RNA polymerase II activating transcription factor binding [MF] |
CG_hsf1_promoter_n_RM_14_72_2 | ![]() |
![]() |
2 | 0.5 | 1.56E-04 | COL2A1 | collagen type II [CC] |
CG_hsf1_promoter_n_RM_14_13_5 | ![]() |
![]() |
3 | 0.5 | 3.24E-04 | HMGB1, NFYB | repressing transcription factor binding [MF] |
CG_hsf1_promoter_n_RM_14_83_9 | ![]() |
![]() |
3 | 0.5 | 3.66E-04 | IRS2, AKT2 | negative regulation of plasma membrane long-chain fatty acid transport [BP], positive regulation of glycogen biosynthetic process [BP], positive regulation of fatty acid beta-oxidation [BP] |
CG_hsf1_promoter_n_RM_12_36_4 | ![]() |
![]() |
4 | 0.75 | 4.17E-04 | USP12, USP4, PDGFRB, SLC16A1 | cell migration involved in coronary angiogenesis [BP], mevalonate transport [BP], ubiquitin-specific protease activity [MF], protein deubiquitination [BP], mevalonate transmembrane transporter activity [MF] |
CG_hsf1_promoter_n_RM_12_129_6 | ![]() |
![]() |
4 | 0.75 | 3.09E-04 | STK10, ROCK2, GFPT1 | glucosamine biosynthetic process [BP], polo kinase kinase activity [MF], positive regulation of centrosome duplication [BP] |
CG_hsf1_promoter_n_RM_12_86_3 | ![]() |
![]() |
2 | 0.5 | 4.43E-04 | MEX3D, CIZ1, UBE2N, CTBP1 | positive regulation of histone modification [BP], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], maintenance of nucleus location [BP], regulation of transcription by chromatin organization [BP] |
CG_hsf1_promoter_n_RM_16_16_3 | ![]() |
![]() |
3 | 0.5 | 3.68E-04 | SMARCC1, SMARCC2 | npBAF complex [CC], nBAF complex [CC], SWI/SNF complex [CC], nucleosome disassembly [BP] |
CG_hsf1_promoter_n_RM_14_46_6 | ![]() |
![]() |
3 | 0.5 | 5.19E-04 | CLIP1, LUZP1, TUBGCP2 | neural fold bending [BP], macropinosome [CC], cytoplasmic microtubule [CC] |
CG_hsf1_promoter_n_RM_12_121_2 | ![]() |
![]() |
3 | 0.75 | 2.85E-04 | CELSR1, ATE1 | protein arginylation [BP], protein localization involved in establishment of planar polarity [BP], arginyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_12_22_6 | ![]() |
![]() |
3 | 0.75 | 2.88E-04 | TRMT61B | mitochondrial tRNA methylation [BP] |
CG_hsf1_promoter_n_RM_12_139_4 | ![]() |
![]() |
6 | 0.75 | 3.08E-04 | DGKI, TNK2 | GTPase inhibitor activity [MF] |
CG_hsf1_promoter_n_RM_14_40_2 | ![]() |
![]() |
2 | 0.5 | 4.49E-04 | ABCB6 | heme-transporting ATPase activity [MF] |
CG_hsf1_promoter_n_RM_12_120_10 | ![]() |
![]() |
2 | 0.5 | 2.03E-04 | HACE1, DUSP16, DPM3, CCDC64B | MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP], MAPK export from nucleus [BP], Rab GTPase binding [MF] |
CG_hsf1_promoter_n_RM_14_93_2 | ![]() |
![]() |
2 | 0.5 | 3.21E-04 | CELSR1, NCOR1, PCYT2 | protein localization involved in establishment of planar polarity [BP], regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP], ethanolamine-phosphate cytidylyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_14_54_4 | ![]() |
![]() |
2 | 0.5 | 2.58E-04 | AMPH, INTS6, SRCIN1, ARHGDIA, DFNB31 | cytoskeleton [CC], regulation of protein localization [BP], stereocilium [CC], actin cytoskeleton [CC] |
CG_hsf1_promoter_n_RM_12_11_4 | ![]() |
![]() |
3 | 0.75 | 3.27E-04 | VAV2, TOP2A, WDFY1, FLT1, EEA1 | positive regulation of phosphatidylinositol 3-kinase activity [BP], 1-phosphatidylinositol binding [MF], viral integration complex [CC], DNA topoisomerase complex (ATP-hydrolyzing) [CC], serine-pyruvate aminotransferase complex [CC] |
CG_hsf1_promoter_n_RM_14_10_2 | ![]() |
![]() |
3 | 0.5 | 3.07E-04 | CD59, PDGFRB | cell migration involved in coronary angiogenesis [BP], negative regulation of activation of membrane attack complex [BP] |
CG_hsf1_promoter_n_RM_16_7_2 | ![]() |
![]() |
5 | 0.5 | 1.75E-04 | SLC26A6, GCLC | glutamate-cysteine ligase activity [MF], formate transmembrane transporter activity [MF], glutamate-cysteine ligase complex [CC] |
CG_hsf1_promoter_n_RM_12_14_3 | ![]() |
![]() |
3 | 0.75 | 4.28E-04 | TRIM9 | negative regulation of SNARE complex assembly [BP] |
CG_hsf1_promoter_n_RM_12_123_5 | ![]() |
![]() |
3 | 0.75 | 3.81E-04 | REV1 | error-prone translesion synthesis [BP] |
CG_hsf1_promoter_n_RM_12_95_7 | ![]() |
![]() |
2 | 0.5 | 4.45E-04 | TSNARE1, RCHY1 | ubiquitin ligase complex [CC], synaptic vesicle exocytosis [BP] |
CG_hsf1_promoter_n_RM_12_108_4 | ![]() |
![]() |
4 | 0.75 | 3.52E-04 | PTPN2, DENND1A, DUSP16, SBF1 | protein dephosphorylation [BP], phosphoprotein phosphatase activity [MF], Rab guanyl-nucleotide exchange factor activity [MF] |
CG_hsf1_promoter_n_RM_14_87_1 | ![]() |
![]() |
4 | 0.5 | 2.68E-04 | HRAS, RASGRP1, ACOT12, CRK | acetyl-CoA hydrolase activity [MF], insulin receptor signaling pathway [BP], blood coagulation [BP], regulation of actin cytoskeleton organization [BP], Ras protein signal transduction [BP], regulation of Rho GTPase activity [BP], activation of MAPKK activity [BP], small GTPase mediated signal transduction [BP], positive regulation of miRNA metabolic process [BP], positive regulation of ruffle assembly [BP], regulation of small GTPase mediated signal transduction [BP], regulation of Rac protein signal transduction [BP] |
CG_hsf1_promoter_n_RM_14_48_5 | ![]() |
![]() |
2 | 0.5 | 5.35E-04 | CDH2, DLG5, IQSEC1 | regulation of ARF protein signal transduction [BP], cell-cell adherens junction [CC] |
CG_hsf1_promoter_n_RM_16_5_2 | ![]() |
![]() |
4 | 0.5 | 3.35E-04 | SLC37A4, CIZ1 | glucose-6-phosphate transmembrane transporter activity [MF], maintenance of nucleus location [BP] |
CG_hsf1_promoter_n_RM_14_44_2 | ![]() |
![]() |
3 | 0.5 | 3.90E-04 | SDC1, CHST1, ADRA1D, CARS2 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [BP], myoblast development [BP], cysteinyl-tRNA aminoacylation [BP], cysteine-tRNA ligase activity [MF], keratan sulfotransferase activity [MF], glycosaminoglycan biosynthetic process [BP] |
CG_hsf1_promoter_n_RM_14_85_5 | ![]() |
![]() |
4 | 0.5 | 4.65E-04 | SMARCC1, DLG4, PPP4R1, SMEK1, SHANK1, SMARCC2 | excitatory synapse [CC], protein phosphatase 4 complex [CC], ionotropic glutamate receptor binding [MF], dendritic spine morphogenesis [BP], scaffold protein binding [MF], vocalization behavior [BP], protein localization to synapse [BP], npBAF complex [CC], nBAF complex [CC], nucleosome disassembly [BP], positive regulation of excitatory postsynaptic membrane potential [BP], SWI/SNF complex [CC] |
CG_hsf1_promoter_n_RM_12_38_6 | ![]() |
![]() |
2 | 0.5 | 3.41E-04 | TOLLIP, ACOT12 | interleukin-18 receptor complex [CC], acyl-CoA metabolic process [BP] |
CG_hsf1_promoter_n_RM_14_33_4 | ![]() |
![]() |
5 | 0.5 | 2.95E-04 | TMEM229A, FECH, GLI3 | detection of UV [BP], anterior semicircular canal development [BP], lambdoid suture morphogenesis [BP], lateral semicircular canal development [BP], sagittal suture morphogenesis [BP], lateral ganglionic eminence cell proliferation [BP], host cell nucleus [CC] |
CG_hsf1_promoter_n_RM_14_59_5 | ![]() |
![]() |
6 | 1.0 | 2.47E-04 | GGT7, CD59 | anchored to external side of plasma membrane [CC] |
CG_hsf1_promoter_n_RM_14_89_3 | ![]() |
![]() |
4 | 0.75 | 3.80E-04 | CAMK2B, HMGB1 | inhibitory G-protein coupled receptor phosphorylation [BP], negative regulation of apoptotic cell clearance [BP] |
CG_hsf1_promoter_n_RM_14_49_6 | ![]() |
![]() |
7 | 1.0 | 4.85E-04 | KCNJ11, SLC24A6 | sarcolemma [CC], regulation of insulin secretion [BP], ATP-sensitive potassium channel complex [CC] |
CG_hsf1_promoter_n_RM_12_90_4 | ![]() |
![]() |
3 | 0.75 | 2.43E-04 | MED13, LRP6, FZD5, NCOR1, STRA13 | thyroid hormone receptor binding [MF], Wnt-protein binding [MF], Wnt-activated receptor activity [MF], Wnt receptor signaling pathway involved in dorsal/ventral axis specification [BP], thalamus development [BP], cell division [BP] |
CG_hsf1_promoter_n_RM_12_136_4 | ![]() |
![]() |
3 | 0.75 | 3.93E-04 | MED20, TMEM18, ZBTB14, GNB1, NOTCH1, STAT5B, FOXO1, DVL1, AKT1, MYO1C, CRK, REV1, MAFA, BNC2 | lateral plasma membrane [CC], cellular response to hormone stimulus [BP], positive regulation of cellular component movement [BP], regulation of transcription, DNA-dependent [BP], response to hypoxia [BP], anagen [BP], transcription, DNA-dependent [BP], T cell homeostasis [BP], negative regulation of stress-activated MAPK cascade [BP], nucleoplasm [CC], cellular response to hypoxia [BP], positive regulation of glucose metabolic process [BP], positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP] |
CG_hsf1_promoter_n_RM_14_50_3 | ![]() |
![]() |
5 | 0.5 | 2.70E-04 | MYH9, ADAM19 | membrane protein ectodomain proteolysis [BP], monocyte differentiation [BP] |
CG_hsf1_promoter_n_RM_12_79_4 | ![]() |
![]() |
3 | 0.75 | 2.17E-04 | PITPNA, BICD2, MYO5B | stearic acid binding [MF], Rab GTPase binding [MF] |
CG_hsf1_promoter_n_RM_14_80_7 | ![]() |
![]() |
6 | 0.75 | 3.17E-04 | HS6ST1, TNS3 | lung alveolus development [BP] |
CG_hsf1_promoter_n_RM_14_2_2 | ![]() |
![]() |
2 | 0.5 | 3.67E-04 | SSBP3 | prechordal plate formation [BP], midbrain-hindbrain boundary initiation [BP] |
CG_hsf1_promoter_n_RM_16_12_6 | ![]() |
![]() |
3 | 0.5 | 3.63E-04 | RHOG, ROCK2, JAK1, RPS6KA2 | intracellular signal transduction [BP], Rac protein signal transduction [BP] |
CG_hsf1_promoter_n_RM_12_134_3 | ![]() |
![]() |
3 | 0.5 | 2.49E-04 | HOXA5, GPR143, CTBP1 | cell-cell signaling involved in mammary gland development [BP], L-DOPA binding [MF], L-DOPA receptor activity [MF], regulation of transcription by chromatin organization [BP] |
CG_hsf1_promoter_n_RM_12_100_3 | ![]() |
![]() |
3 | 0.5 | 2.27E-04 | TNK2, PCYT2, YES1, NACC2 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], epidermal growth factor receptor binding [MF], ethanolamine-phosphate cytidylyltransferase activity [MF], non-membrane spanning protein tyrosine kinase activity [MF] |
CG_hsf1_promoter_n_RM_16_1_3 | ![]() |
![]() |
2 | 0.5 | 2.31E-04 | DEAF1, P4HB, CPT1A, ZNF202, MTOR | regulation of fatty acid oxidation [BP], positive regulation of lipid biosynthetic process [BP], germ cell development [BP], regulation of fatty acid beta-oxidation [BP], lipid metabolic process [BP] |
CG_hsf1_promoter_n_RM_12_125_4 | ![]() |
![]() |
3 | 0.75 | 2.40E-04 | KIF1A, KIF9, HAUS3 | microtubule associated complex [CC], microtubule [CC] |
CG_hsf1_promoter_n_RM_12_98_5 | ![]() |
![]() |
4 | 0.75 | 4.73E-04 | PTCH1, EIF6, HTR1D | ribosomal subunit export from nucleus [BP], smoothened binding [MF], ribosomal large subunit binding [MF], response to chlorate [BP], intestine smooth muscle contraction [BP], hedgehog family protein binding [MF], neural plate axis specification [BP] |
CG_hsf1_promoter_n_RM_16_10_3 | ![]() |
![]() |
3 | 0.5 | 3.06E-04 | TPMT, ABCB6, ALG12 | heme-transporting ATPase activity [MF], thiopurine S-methyltransferase activity [MF], dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [MF], alpha-1,6-mannosyltransferase activity [MF] |
CG_hsf1_promoter_n_RM_14_14_2 | ![]() |
![]() |
3 | 0.5 | 1.84E-04 | CDC37, KCNMA1, PRKAA1, GSK3B, HMGB1 | negative regulation of cell volume [BP], cellular potassium ion homeostasis [BP], negative regulation of apoptotic cell clearance [BP], protein complex [CC], canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], glucose metabolic process [BP], tau-protein kinase activity [MF], cold acclimation [BP], eye blink reflex [BP], negative regulation of glucosylceramide biosynthetic process [BP] |
CG_hsf1_promoter_n_RM_14_56_6 | ![]() |
![]() |
3 | 0.5 | 2.02E-04 | RB1CC1 | ULK1-ATG13-FIP200 complex [CC] |
CG_hsf1_promoter_n_RM_12_84_5 | ![]() |
![]() |
2 | 0.5 | 5.04E-04 | FGF8, JUN, TP53BP2, PITPNA | cell cycle [BP], regulation of cell cycle [BP], leading edge cell differentiation [BP], positive regulation of cell division [BP], cellular response to potassium ion starvation [BP], stearic acid binding [MF], outflow tract morphogenesis [BP], response to radiation [BP], cell migration involved in mesendoderm migration [BP] |
CG_hsf1_promoter_n_RM_12_126_5 | ![]() |
![]() |
6 | 0.75 | 1.63E-04 | KDM5B | histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], histone demethylase activity (H3-trimethyl-K4 specific) [MF] |
CG_hsf1_promoter_n_RM_16_17_1 | ![]() |
![]() |
3 | 0.5 | 2.91E-04 | PLAG1, SLC6A3 | multicellular organism growth [BP], dopamine transmembrane transporter activity [MF], dopamine:sodium symporter activity [MF] |
CG_hsf1_promoter_n_RM_14_70_7 | ![]() |
![]() |
2 | 0.5 | 4.22E-04 | JHDM1D, SMAD9 | midbrain development [BP] |
CG_hsf1_promoter_n_RM_12_10_2 | ![]() |
![]() |
2 | 0.5 | 3.30E-04 | TERF2, BAD, NSMCE4A, HID1 | extrinsic to Golgi membrane [CC], response to brefeldin A [BP], chromosome, telomeric region [CC], cellular response to chromate [BP] |
CG_hsf1_promoter_n_RM_12_1_3 | ![]() |
![]() |
4 | 0.75 | 5.17E-04 | NRL, IMPAD1 | positive regulation of rhodopsin gene expression [BP], 3'-nucleotidase activity [MF] |
CG_hsf1_promoter_n_RM_12_64_7 | ![]() |
![]() |
5 | 0.75 | 4.35E-04 | DLG4 | P2Y1 nucleotide receptor binding [MF] |
CG_hsf1_promoter_n_RM_12_3_5 | ![]() |
![]() |
3 | 0.75 | 2.95E-04 | CHD8, PAF1, RBL1, FOXH1, SURF6, PYGO1 | nucleoplasm part [CC], positive regulation of transcription from RNA polymerase II promoter [BP] |
CG_hsf1_promoter_n_RM_14_66_2 | ![]() |
![]() |
2 | 0.5 | 4.47E-04 | OPLAH, FBXO2 | 5-oxoprolinase (ATP-hydrolyzing) activity [MF], regulation of protein ubiquitination [BP] |
CG_hsf1_promoter_n_RM_12_16_2 | ![]() |
![]() |
3 | 0.5 | 2.72E-04 | ATE1, HCN4, MKX, TRPM5 | tendon sheath development [BP], protein arginylation [BP], arginyltransferase activity [MF], sodium channel activity [MF] |
CG_hsf1_promoter_n_RM_12_124_4 | ![]() |
![]() |
3 | 0.75 | 3.97E-04 | GLRX2, IMPAD1 | arsenate reductase (glutaredoxin) activity [MF], 3'-nucleotidase activity [MF] |
CG_hsf1_promoter_n_RM_16_9_1 | ![]() |
![]() |
5 | 0.5 | 5.23E-04 | FGFR2, LRP8 | fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP], ammon gyrus development [BP], fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP], coronal suture morphogenesis [BP], fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP] |
CG_hsf1_promoter_n_RM_14_92_4 | ![]() |
![]() |
3 | 0.5 | 5.47E-04 | DLG4, TWIST1, ADAMTS8, ENTPD4, MAFA, HIVEP2, CCNL2 | low affinity phosphate transmembrane transporter activity [MF], transcription, DNA-dependent [BP], UDP catabolic process [BP], P2Y1 nucleotide receptor binding [MF], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP], cell proliferation involved in heart valve development [BP] |
CG_hsf1_promoter_n_RM_12_62_5 | ![]() |
![]() |
3 | 0.75 | 1.77E-04 | ERCC1, FOXA1 | protein domain specific binding [MF] |
CG_hsf1_promoter_n_RM_14_41_4 | ![]() |
![]() |
2 | 0.5 | 1.70E-04 | TNNT2, SRXN1, WNT2 | sulfiredoxin activity [MF], atrial cardiac muscle tissue morphogenesis [BP] |
CG_hsf1_promoter_n_RM_12_66_3 | ![]() |
![]() |
3 | 0.75 | 3.38E-04 | TRPV4 | cortical microtubule organization [BP], osmosensory signaling pathway [BP] |
CG_hsf1_promoter_n_RM_12_132_9 | ![]() |
![]() |
3 | 0.75 | 4.27E-04 | GPR143, GDNF, LTF, PNKP, AKT1 | L-DOPA binding [MF], positive regulation of monooxygenase activity [BP], glycogen cell differentiation involved in embryonic placenta development [BP], L-DOPA receptor activity [MF], phagocytic vesicle lumen [CC], nucleotide phosphorylation [BP] |
CG_hsf1_promoter_n_RM_14_21_4 | ![]() |
![]() |
3 | 0.5 | 2.58E-04 | PTK2, CDC42BPB, FAT1 | establishment or maintenance of cell polarity [BP], central nervous system neuron axonogenesis [BP], negative regulation of cell-cell adhesion [BP], cell leading edge [CC] |
CG_hsf1_promoter_n_RM_12_92_5 | ![]() |
![]() |
2 | 0.5 | 3.77E-04 | REV1 | deoxycytidyl transferase activity [MF], error-prone translesion synthesis [BP] |
CG_hsf1_promoter_n_RM_12_122_2 | ![]() |
![]() |
4 | 0.75 | 3.89E-04 | TOLLIP, TK2 | deoxycytidine kinase activity [MF], interleukin-18 receptor complex [CC], thymidine kinase activity [MF], interleukin-1, Type I receptor binding [MF], deoxycytidine metabolic process [BP] |
CG_hsf1_promoter_n_RM_12_21_11 | ![]() |
![]() |
3 | 0.5 | 4.72E-04 | TOLLIP, DEGS2 | interleukin-18 receptor complex [CC], sphingolipid delta-4 desaturase activity [MF], sphingosine hydroxylase activity [MF] |
CG_hsf1_promoter_n_RM_14_95_4 | ![]() |
![]() |
3 | 0.5 | 4.06E-04 | GATAD2B, SUMO2, EIF4ENIF1, PIAS2 | protein sumoylation [BP], nuclear speck [CC] |
CG_hsf1_promoter_n_RM_14_84_6 | ![]() |
![]() |
4 | 0.75 | 4.70E-04 | POU3F1, DICER1, ELAVL3, DUSP7, FGFR2, DUSP10, MEX3D | AU-rich element binding [MF], MAP kinase tyrosine/serine/threonine phosphatase activity [MF], inactivation of MAPK activity [BP], MAP kinase phosphatase activity [MF], hair follicle morphogenesis [BP], forebrain development [BP], myelination in peripheral nervous system [BP] |
CG_hsf1_promoter_n_RM_14_82_3 | ![]() |
![]() |
3 | 0.5 | 3.54E-04 | AKT1, MAPK9, IRS1, IGF2 | positive regulation of glycogen biosynthetic process [BP], insulin-like growth factor receptor signaling pathway [BP], regulation of glycogen biosynthetic process [BP], insulin-like growth factor receptor binding [MF], positive regulation of glucose import [BP], protein kinase B signaling cascade [BP], glycogen biosynthetic process [BP], positive regulation of nitric oxide biosynthetic process [BP], positive regulation of insulin receptor signaling pathway [BP], positive regulation of glucose metabolic process [BP], insulin receptor binding [MF] |
CG_hsf1_promoter_n_RM_12_59_3 | ![]() |
![]() |
2 | 0.5 | 3.46E-04 | BCL11B, PNKP | striatal medium spiny neuron differentiation [BP], nucleotide phosphorylation [BP], olfactory bulb axon guidance [BP] |
CG_hsf1_promoter_n_RM_12_12_7 | ![]() |
![]() |
4 | 0.75 | 5.96E-04 | NR6A1, SATB2 | transcription factor complex [CC] |
CG_hsf1_promoter_n_RM_14_45_3 | ![]() |
![]() |
3 | 0.5 | 3.63E-04 | ANKLE2, LUZP1, SLC19A1, MFSD10 | neural fold bending [BP], methotrexate transport [BP], tetracycline transporter activity [MF], tetracycline transport [BP], mitotic nuclear envelope reassembly [BP], methotrexate transporter activity [MF] |
CG_hsf1_promoter_n_RM_12_70_6 | ![]() |
![]() |
3 | 0.75 | 3.34E-04 | SYNJ1, BIN3, ADRA2B, ASAP3, INSR | activation of protein kinase B activity [BP], protein domain specific binding [MF], synaptic vesicle endocytosis [BP] |
CG_hsf1_promoter_n_RM_14_51_2 | ![]() |
![]() |
5 | 0.5 | 4.72E-04 | CNR1, PRKAR1B, SYT7, MYH10 | regulation of insulin secretion [BP], plasma membrane repair [BP], exocytosis [BP] |
CG_hsf1_promoter_n_RM_14_31_2 | ![]() |
![]() |
5 | 0.5 | 2.37E-04 | CBS, TNK2, FAM189B, CHST1 | cystathionine beta-synthase activity [MF], WW domain binding [MF], cysteine biosynthetic process via cystathionine [BP], keratan sulfotransferase activity [MF], cysteine biosynthetic process from serine [BP], homocysteine catabolic process [BP] |
CG_hsf1_promoter_n_RM_14_86_7 | ![]() |
![]() |
3 | 0.5 | 2.77E-04 | CDKN2A, SIK1, NOTCH1, LGR4 | somatic stem cell division [BP], regulation of myotube differentiation [BP], negative regulation of cell-substrate adhesion [BP], negative regulation of transcription, DNA-dependent [BP], anoikis [BP] |
CG_hsf1_promoter_n_RM_12_6_5 | ![]() |
![]() |
5 | 0.75 | 1.62E-04 | APBA1, RAB3A, NEUROD2 | response to electrical stimulus [BP], glutamate secretion [BP], cerebellar cortex development [BP] |
CG_hsf1_promoter_n_RM_12_111_3 | ![]() |
![]() |
3 | 0.5 | 2.48E-04 | KDM5B, GCLM | histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], positive regulation of glutamate-cysteine ligase activity [BP] |
CG_hsf1_promoter_n_RM_12_116_5 | ![]() |
![]() |
4 | 1.0 | 4.13E-04 | TTLL1, LBX1 | tubulin-glutamic acid ligase activity [MF], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP] |
CG_hsf1_promoter_n_RM_14_53_3 | ![]() |
![]() |
5 | 0.5 | 3.50E-04 | NKX3-1, MYO1C | positive regulation of androgen secretion [BP], MADS box domain binding [MF], myosin I complex [CC], positive regulation of vascular endothelial growth factor signaling pathway [BP] |
CG_hsf1_promoter_n_RM_14_37_3 | ![]() |
![]() |
4 | 0.75 | 3.96E-04 | KPNA1, NPHP4, CASP3 | hippo signaling cascade [BP], apoptotic DNA fragmentation [BP] |
CG_hsf1_promoter_n_RM_12_72_8 | ![]() |
![]() |
4 | 0.75 | 3.89E-04 | SYMPK, DLG4, NUDT3, AP1S3, SHANK1, MBD2, XRCC3, SRCIN1, SIAH1, CHD1 | excitatory synapse [CC], cellular membrane organization [BP], ionotropic glutamate receptor binding [MF], dendritic spine morphogenesis [BP], postsynaptic density [CC], cytoplasm [CC], vocalization behavior [BP], protein localization to synapse [BP], ionotropic glutamate receptor complex [CC], positive regulation of excitatory postsynaptic membrane potential [BP], scaffold protein binding [MF] |
CG_hsf1_promoter_n_RM_14_69_5 | ![]() |
![]() |
4 | 0.5 | 3.36E-04 | GXYLT1, SYNE1, NFIB | UDP-xylosyltransferase activity [MF], nucleus organization [BP], chondrocyte differentiation [BP] |
CG_hsf1_promoter_n_RM_14_88_3 | ![]() |
![]() |
4 | 0.75 | 2.51E-04 | GFRA4, NOTCH1, PKMYT1, ARPP19, TUBGCP2, ITGB1 | negative regulation of ossification [BP], G2/M transition of mitotic cell cycle [BP], response to gonadotropin stimulus [BP], negative regulation of anoikis [BP] |
CG_hsf1_promoter_n_RM_12_53_4 | ![]() |
![]() |
4 | 0.5 | 1.92E-04 | CTBP1 | regulation of transcription by chromatin organization [BP] |
CG_hsf1_promoter_n_RM_12_68_3 | ![]() |
![]() |
3 | 0.5 | 4.41E-04 | SAV1 | intestinal epithelial cell differentiation [BP] |
CG_hsf1_promoter_n_RM_12_5_2 | ![]() |
![]() |
2 | 0.5 | 2.01E-04 | GNPNAT1, PRKCQ | glucosamine 6-phosphate N-acetyltransferase activity [MF], positive regulation of T-helper 2 cell activation [BP] |
CG_hsf1_promoter_n_RM_12_85_6 | ![]() |
![]() |
2 | 0.5 | 4.25E-04 | GPR143 | L-DOPA binding [MF], L-DOPA receptor activity [MF] |
CG_hsf1_promoter_n_RM_14_55_3 | ![]() |
![]() |
3 | 0.5 | 4.01E-04 | GNPNAT1, TOLLIP, HID1 | interleukin-18 receptor complex [CC], response to brefeldin A [BP], glucosamine 6-phosphate N-acetyltransferase activity [MF], extrinsic to Golgi membrane [CC] |
CG_hsf1_promoter_n_RM_14_94_2 | ![]() |
![]() |
2 | 0.5 | 2.95E-04 | RPS6KA3 | regulation of DNA-dependent transcription in response to stress [BP] |
CG_hsf1_promoter_n_RM_16_15_3 | ![]() |
![]() |
2 | 0.5 | 3.44E-04 | AMBRA1, ARRDC3, STIL | neural tube development [BP], negative regulation of heat generation [BP], negative regulation of locomotion involved in locomotory behavior [BP], embryonic axis specification [BP] |
CG_hsf1_promoter_n_RM_14_57_5 | ![]() |
![]() |
6 | 1.0 | 3.21E-04 | RNGTT, POLR2L | 7-methylguanosine mRNA capping [BP] |
CG_hsf1_promoter_n_RM_12_23_6 | ![]() |
![]() |
4 | 0.5 | 5.97E-04 | ADRA1D | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [BP] |
CG_hsf1_promoter_n_RM_12_51_6 | ![]() |
![]() |
3 | 0.75 | 4.58E-04 | RBBP7, SSBP3 | prechordal plate formation [BP], cellular heat acclimation [BP], midbrain-hindbrain boundary initiation [BP] |
CG_hsf1_promoter_n_RM_14_96_7 | ![]() |
![]() |
4 | 0.5 | 3.70E-04 | LUZP1, MEX3D | neural fold bending [BP], mRNA localization resulting in posttranscriptional regulation of gene expression [BP] |
CG_hsf1_promoter_n_RM_16_13_1 | ![]() |
![]() |
3 | 0.5 | 5.12E-04 | BID, SMAD7, PDE2A, NR4A2 | habenula development [BP], transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity [MF], ubiquitin protein ligase binding [MF], negative regulation of protein import into nucleus, translocation [BP], protein targeting to mitochondrion [BP] |